Update HSBC (HBC)

08/30/2010 3:47 pm EST

Focus: STOCKS

Jim Jubak

Founder and Editor, JubakPicks.com

It’s by no means a done deal—nothing is in South Africa these days—but Nedbank, the South African bank majority owned by insurer Old Mutual (OML.L), is HSBC’s (HBC) deal to lose.

HSBC beat out rival Standard Chartered (SCBFF.PK) for the right to hammer out a formal offer to acquire South Africa’s fourth largest bank over the next two months. I think HSBC will pull it off. Old Mutual own 51% of Nedbank and the insurer is a motivated seller because the company is selling assets to pay down debt. HSBC won’t be able to gain 100% of Nedbank’s outstanding shares because South African law reserves a percentage of shares for black investors. But the company should be able to gain the 70% of shares that it has said will let it achieve it strategic goals.

And what are those goals?

First, but not foremost, HSBC wants to gain a foothold in Africa’s largest economy.

Second, but more important, HSBC wants to stake a claim to financing the increasingly important trade between Africa and Asia. Roughly a third of Africa’s exports—mostly minerals and other commodities—head for Asia these days. Ten years ago only 1% of Africa’s exports went to China. Today China is the destination for 10% of the continent’s exports. And with China investing in Africa’s commodities as fast as it can identify deals and funding big infrastructure projects like the proposed Durban to Johannesburg high-speed rail line that Africa-China traffic will continue to grow.

And now that HSBC has defined itself as an Asian bank, it can’t afford not to have a presence in Africa.

The price looks reasonable at an estimated $8 billion. And I think HSBC will manage the sensitive politics of South Africa well enough to ink the deal.

As of August 30 I’m keeping my target price for this Jubak’s Pick at $67 a share by June 2011.

Full disclosure: I don’t own shares of any company mentioned in this post in my personal account.

Related Articles on STOCKS

Keyword Image
11 Reasons to Buy Microsoft
16 hours ago

For our latest recommendation, we revisit one of the world's most prominent technology companies, Mi...

Keyword Image
A Trio of Top-Tier Biotechs
16 hours ago

We hold three biotech stocks in our growth portfolio — Biogen (BIIB), Bioverativ (BIVV), and R...

Keyword Image
Saudis, Oil and ETFs
16 hours ago

Under the guise of clamping down on “widespread corruption,” Prince Mohammed bin Salman ...